Pfizer, WashU strike deal on research pact

Two of St. Louis’ major powerhouses announced a unique partnership today whose purpose is to discover new uses for existing drugs and to accelerate the development of scientific knowledge about human biology and disease.

Pfizer Inc. and the Washington University School of Medicine have struck an agreement that will provide university researchers with confidential access to a virtual medicine cabinet of hundreds of chemical compounds that the pharmaceutical company has investigated to varying degrees or are currently being tested on humans.

[St. Louis Post Dispatch]